Achmea Investment Management B.V. Bristol Myers Squibb CO Transaction History

Achmea Investment Management B.V.

$5.59 Billion
Q2 2024

A detailed history of Achmea Investment Management B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Achmea Investment Management B.V. holds 306,813 shares of BMY stock, worth $16.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

306,813

Previous 277,703 10.48%

Holding current value

$16.3 Million

Previous $15.1 Million 15.39%

% of portfolio

0.23%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $1.17 Million - $1.54 Million	29,110 Added 10.48%	306,813 $12.7 Million
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $354,236 - $401,635	7,383 Added 2.73%	277,703 $15.1 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $6.34 Million - $7.56 Million	-130,743 Reduced 32.6%	270,320 $13.9 Million
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $2.55 Million - $2.86 Million	-44,120 Reduced 9.91%	401,063 $23.3 Million
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $2.47 Million - $2.74 Million	38,793 Added 9.55%	445,183 $28.5 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $4.02 Million - $4.56 Million	61,211 Added 17.73%	406,390 $28.2 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $965,431 - $1.14 Million	14,098 Added 4.26%	345,179 $23.3 Million
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $1,304 - $771,166	-10,036 Reduced 2.94%	331,081 $23.5 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $10.7 Million - $11.8 Million	147,744 Added 76.4%	341,117 $26.3 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $6.43 Million - $7.71 Million	104,575 Added 117.77%	193,373 $14.1 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $1.57 Million - $1.83 Million	-29,328 Reduced 24.83%	88,798 $5.54 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $219,106 - $256,654	3,703 Added 3.24%	118,126 $6.99 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $2.89 Million - $3.15 Million	-46,695 Reduced 28.98%	114,423 $7.65 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $6.01 Million - $6.76 Million	-101,242 Reduced 38.59%	161,118 $10.2 Million
Q4 2020 Feb 22, 2021	SELL	$57.74 - $65.43 $1.9 Million - $2.15 Million	-32,913 Reduced 11.15%	262,360 $16.3 Million
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $17 Million - $18.8 Million	295,273 New	295,273 $17.8 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $11 Million - $15.9 Million	-236,459 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $5.6 Million - $7.31 Million	113,897 Added 92.93%	236,459 $15.2 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $575,855 - $682,759	-13,464 Reduced 9.9%	122,562 $6.22 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $708,565 - $783,519	15,880 Added 13.22%	136,026 $6.17 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $1.88 Million - $2.24 Million	-41,662 Reduced 25.75%	120,146 $5.73 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $959,791 - $1.24 Million	19,684 Added 13.85%	161,808 $8.41 Million
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $1.68 Million - $1.89 Million	-30,386 Reduced 17.61%	142,124 $8.82 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $475,537 - $592,704	9,411 Added 5.77%	172,510 $9.54 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $4.73 Million - $5.45 Million	78,957 Added 93.84%	163,099 $10.3 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $1.78 Million - $1.94 Million	29,732 Added 54.64%	84,142 $5.16 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $1.12 Million - $1.29 Million	20,229 Added 59.18%	54,410 $3.47 Million
Q2 2017 Aug 29, 2017	BUY	N/A	34,181	34,181 $1.9 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Bristol Myers Squibb CO Transaction History